Xeltis is a commercial-stage MedTech company developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. The company aims to improve patient outcomes in hemodialysis vascular access and cardiovascular replacements, addressing significant unmet needs in these areas.

Total raised
$22
tracked to date
Latest round
$22
Jul 28, 2026
Known investors
6
led by Horizon 3 Healthcare

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Netherlands.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 Netherlands Funding Report

Read the Q3 2026 Netherlands report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-netherlands-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Netherlands Funding Report</a>

Funding history

  1. 1
    $22Jul 28, 2026

    Led by Horizon 3 Healthcare

    Announcement ↗

Founder

Eliane Schutte
Eliane Schutte
Chief Executive Officer

Investors in Xeltis

Backers from this company's tracked funding rounds.

  • HHorizon 3 HealthcareLead investorVC firm
  • EEuropean Innovation CouncilVC firm
  • IInvest-NLVC firm
  • VVI PartnersVC firm
  • EEQT Life SciencesVC firm
  • DDaVitaVC firm

Xeltis in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile

Xeltis — Health startup in Netherlands | Datapile